Divisions
Hematology and Oncology
Division Faculty
Research
Pediatric Hematology and Oncology Fellowship
Patient Care
Contact Us

The Pediatric Hematology and Oncology Fellowship at Vanderbilt is a three-year program designed to prepare individuals who have completed their general pediatric training for academic positions. 

Specific goals include:

  • Equipping trainees with the skills and knowledge necessary to assume responsibility for the diagnostic evaluation and management of children with cancer and blood disorders
  • Developing an independent research program relevant to pediatric hematology and oncology
  • Cultivating skills in teaching. 

The program is supported by training grants from the National Heart, Lung, and Blood Institute and the National Cancer Institute. Monroe Carell Jr. Children's Hospital at Vanderbilt is a full member of the Children's Oncology Group.

The first year of the fellowship focuses on clinical training in pediatric hematology and oncology. Trainees have responsibility for both hospitalized and ambulatory patients. Teaching rounds with a faculty member and a resident team dedicated to hematology and oncology are held daily. Clinics meet daily. First-year fellows spend six months on in-patient service. The remaining portion of the first year is devoted to rotations in outpatient clinics including oncology, hemostasis-thrombosis, hematology, sickle cell disease, neuro-oncology, stem cell transplantation, and rotations in hematopathology, clinical pathology and blood banking and radiation oncology. Three weeks of vacation are provided to fellows.

During the first year, each fellow also participates in a weekly half-day continuity clinic for the care of patients for whom he or she assumes primary responsibility. As a consultant to the house staff and medical students, the fellow has an opportunity to develop skills in clinical teaching. To further this experience as an educator, the fellow participates with the faculty in various teaching conferences. Exposure to clinical research is afforded through participation in the design, implementation, and analysis of therapeutic, epidemiologic, biologic and supportive care studies, many of which are conducted under the aegis of the Children's Oncology Group.

The major portion of the second and third years are devoted to the development of research skills. Fellows having a primary interest in clinical research may have an opportunity to enroll in Master of Public Health (MPH) or Master of Science in Clinical Investigation (MSCI) programs, as well as responsibility in ongoing therapeutic trials. Fellows with laboratory-based research interests may elect to pursue their research experience with any member of the Vanderbilt faculty. The major research focuses within the Division of Pediatric Hematology-Oncology concern the genetic regulation of apoptosis and the mechanisms by which cells develop resistance to chemotherapeutic agents. Throughout the second and the third years, fellows continue to participate in their weekly half-day clinic and also take limited inpatient call each month.

All of the divisional faculty are involved in the training of fellows. Click here to visit our faculty directory.

Formal teaching conferences include a weekly Fellows’ Conference, weekly patient oriented conferences, and a weekly Pediatric Tumor Board.

The Monroe Carell Jr. Children's Hospital at Vanderbilt is the only tertiary care facility for children in middle Tennessee, southern Kentucky, and northern Alabama. It includes 243 medical and surgical beds, a 36-bed intensive care unit, and a five-bed pediatric bone marrow transplantation unit.  It is staffed by  pediatric residents and more than 100 full-time faculty representing all of the pediatric and surgical subspecialities.

The pediatric bone marrow transplantation program is approved by the National Marrow Donor Program and by the Children’s Oncology Group as a Marrow Transplant Center. The Hemostasis-Thrombosis Program includes a federally recognized Comprehensive Hemophilia Treatment Center and active program in thrombophilia. There are over 900 admissions to the Pediatric Hematology-Oncology service annually and over 12,000 annual outpatient visits. The service has active clinical programs for patients with clotting disorders and hemoglobinopathies.  
    
As our training program in pediatric hematology and oncology is supported in part by training grants from the National Institutes of Health, we must restrict applicants to those who are either U.S. citizens or non-citizens admitted for permanent residence. 

The stipend for first year fellows is based on institutional guidelines. Benefits include healthcare coverage, malpractice and disability insurance coverage, social security payments, contributions to a retirement plan, and allowances for meeting travel expenses. For mor einformation, visit the Vanderbilt University Medical Center Office of Graduate Medical Education Web site.  Apply online at Electronic Residency Application System (ERAS). Our training program participates in the National Residency Matching Program (NRMP).

For more information, contact our fellowship coordinator:

Michele Bender
Pediatric Hematology/Oncology
397 PRB
2220 Pierce Ave
Nashville, TN 37232-6310
Phone: (615) 936.6649
Fax: (615) 936.1767
Email: michele.bender@vanderbilt.edu

 



 
Vanderbilt University School Of Medicine
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Department of Pediatrics | 2200 Children's Way | Nashville, Tenn. 37232 | 615.936.1000
© 2014 Vanderbilt University School of Medicine
Monroe Carrell Jr. Children's Hospital at Vanderbilt